Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Selvarangan Ponnazhagan Ph.D.
Professor
Close
E-mail
pons@uab.edu
Visualizations
Co-author Network
Map of Science
Co-investigator Network
Selvarangan Ponnazhagan Ph.D.
Professor
Positions
Senior Scientist (C)
,
UAB Immunology Institute
,
School of Medicine
Senior Scientist (C)
,
Comprehensive Arthritis, Musculoskeletal, Bone and Autoimmunity Center (CAMBAC)
,
School of Medicine
Senior Scientist (C)
,
Comprehensive Diabetes Center
,
School of Medicine
Senior Scientist (C)
,
O'Neal Comprehensive Cancer Center
,
School of Medicine
Senior Scientist (C)
,
Cystic Fibrosis Research Center
,
School of Medicine
Senior Scientist
,
Experimental Therapeutics
,
O'Neal Comprehensive Cancer Center
Senior Scientist (C)
,
Nephrology Research & Training Center
,
General Clinical Research Center
Senior Scientist (C)
,
Global Center for Craniofacial, Oral and Dental Disorders (GC-CODED)
,
School of Dentistry
Senior Scientist (C)
,
Center for Biophysical Sciences and Engineering (CBSE)
,
School of Optometry
Professor (P)
,
Molecular & Cellular Pathology
,
Joint Pathology
Scientist (C)
,
Biomatrix Eng Regen Med (BERM) Center
,
Biomedical Engineering
Publications
Research
Teaching
Background
Contact
Publications
Selected Publications
Academic Article
Filter
Year
Title
Altmetric
2020
Adeno-Associated Virus D-Sequence-Mediated Suppression of Expression of a Human Major Histocompatibility Class II Gene: Implications in the Development of Adeno-Associated Virus Vectors for Modulating Humoral Immune Response
.
Human gene therapy. Clinical development
. 31:565-574.
2020
2018
Pathology, chemoprevention, and preclinical models for target validation in Barrett esophagus
.
Cancer Research
. 78:3747-3754.
2018
2018
Myeloid-derived suppressor cells impair B cell responses in lung cancer through IL-7 and STAT5
.
Journal of Immunology
. 201:278-295.
2018
2017
Silencing of TGF-β1 in tumor cells impacts MMP-9 in tumor microenvironment
.
Scientific Reports
. 7.
2017
2017
Mesenchymal stem cells expressing osteoprotegerin variants inhibit osteolysis in a murine model of multiple myeloma
.
Blood Advances
. 1:2375-2385.
2017
2017
Effects of cellular methylation on transgene expression and site-specific integration of adeno-associated virus
.
Genes
. 8.
2017
2017
Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress
2017
2017
Location of tumor affects local and distant immune cell type and number:
.
Immunity, Inflammation and Disease
. 5:85-94.
2017
2017
Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity
.
Oncotarget
. 8:47675-47690.
2017
2017
Resveratrol induces mitochondria-mediated, caspaseindependent apoptosis in murine prostate cancer cells
.
Oncotarget
. 8:20895-20908.
2017
2016
Immature myeloid cells are critical for enhancing bone fracture healing through angiogenic cascade
.
Bone
. 93:113-124.
2016
2016
Prostate cancer-derived cathelicidin-related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic macrophages
2016
2016
Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment
.
Oncotarget
. 7:75407-75424.
2016
2015
SOCS3 deficiency in myeloid cells promotes tumor development: Involvement of STAT3 activation and myeloid-derived suppressor cells
.
Cancer Immunology Research
. 3:727-740.
2015
2015
Variants of osteoprotegerin lacking trail binding for therapeutic bone remodeling in osteolytic malignancies
.
Molecular Cancer Research
. 13:819-827.
2015
2015
Endostatin: A novel inhibitor of androgen receptor function in prostate cancer
2015
2014
Anterior gradient protein-2 is a regulator of cellular adhesion in prostate cancer
.
PLoS One
. 9.
2014
2014
Detection of Merkel cell polyomavirus in formalin-fixed, paraffin-embedded tissue of merkel cell carcinoma and correlation with prognosis
.
Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
. 55:1057-1062.
2014
2014
The dual targeting of immunosuppressive cells and oxidants promotes effector and memory T-cell functions against lung cancer
.
OncoImmunology
. 3.
2014
2013
Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways
.
Cancer Research
. 73:6609-6620.
2013
2013
Myeloid-derived suppressor cells as osteoclast progenitors: A novel target for controlling osteolytic bone metastasis
.
Cancer Research
. 73:4606-4610.
2013
2013
Myeloid-derived suppressor cells as a novel target for the control of osteolytic bone disease
.
OncoImmunology
. 2.
2013
2013
Muscle-directed anti-Aβ Single-Chain Antibody Delivery Via AAV1 reduces cerebral Aβ load in an Alzheimer's disease mouse model
.
Journal of Molecular Neuroscience
. 49:277-288.
2013
2013
Polyglutamate directed coupling of bioactive peptides for the delivery of osteoinductive signals on allograft bone
.
Clinical materials
. 34:1506-1513.
2013
2013
Role of plasmacytoid dendritic cells in breast cancer bone dissemination
.
OncoImmunology
. 2.
2013
2013
Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer
.
Cancer Research
. 73:672-682.
2013
2012
Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells
.
Journal of Immunology
. 189:4258-4265.
2012
2012
Bone healing by endogenous stem cell mobilization
.
Bone
. 51:635.
2012
2012
DiVerential eVects of low-dose decitabine on immune eVector and suppressor responses in melanoma-bearing mice
2012
2012
Noggin is novel inducer of mesenchymal stem cell adipogenesis: Implications for bone health and obesity
.
Journal of Biological Chemistry
. 287:12241-12249.
2012
2012
Mobilization of bone marrow mesenchymal stem cells in vivo augments bone healing in a mouse model of segmental bone defect
.
Bone
. 50:1012-1018.
2012
2011
Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll-like receptor agonists
.
Cancer Gene Therapy
. 18:850-858.
2011
2011
Conditionally replicating adenovirus expressing TIMP2 increases survival in a mouse model of disseminated ovarian cancer
.
PLoS One
. 6.
2011
2011
LL-37 as a therapeutic target for late stage prostate cancer
2011
2011
Conditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy
.
Clinical Cancer Research
. 17:538-549.
2011
2011
Anti-amyloid-β single-chain antibody brain delivery via aav reduces amyloid load but may increase cerebral hemorrhages in an alzheimer's disease mouse model
.
Journal of Alzheimer's Disease
. 27:23-28.
2011
2010
Bacteriophage hyaluronidase effectively inhibits growth, migration and invasion by disrupting hyaluronan-mediated Erk1/2 activation and RhoA expression in human breast carcinoma cells
.
Cancer Letters
. 298:238-249.
2010
2010
Regulation of the activity of an adeno-associated virus vector cancer vaccine administered with synthetic Toll-like receptor agonists
.
Vaccine
. 28:7837-7843.
2010
2010
Merkel cell carcinoma: Correlation of KIT expression with survival and evaluation of KIT gene mutational status
.
Human Pathology
. 41:1405-1412.
2010
2010
Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton
.
Journal of Cellular Biochemistry
. 111:249-257.
2010
2010
Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect
.
Molecular Therapy
. 18:1026-1034.
2010
2010
Therapeutic potential of genetically modified adult stem cells for osteopenia
2010
2009
Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis
.
Clinical Cancer Research
. 15:7175-7185.
2009
2009
Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4
.
Laboratory Investigation
. 89:1221-1228.
2009
2009
High Cks1 expression in transgenic and carcinogeninitiated mammary tumors is not always accompanied by reduction in p27
Kip1
.
International Journal of Oncology
. 34:1425-1431.
2009
2009
Tumoristatic effects of endostatin in prostate cancer is dependent on androgen receptor status
2009
2009
Detection of Merkel cell polyomavirus in formalin-fixed, paraffin-embedded tissue of Merkel cell carcinoma and its correlation with prognosis.
.
Journal of Clinical Oncology
. 27:6027.
2009
2009
Pulmonary Angiogenesis in a Rat Model of Hepatopulmonary Syndrome
.
Gastroenterology
. 136:1070-1080.
2009
2008
Genetic modification of adeno-associated viral vector type 2 capsid enhances gene transfer efficiency in polarized human airway epithelial cells
.
Human gene therapy. Clinical development
. 19:1407-1414.
2008
2008
Therapeutic potential of mesenchymal stem cells producing interferon-α in a mouse melanoma lung metastasis model
.
Stem Cells
. 26:2332-2338.
2008
2008
Silencing of transforming growth factor-β1 in situ by RNA interference for breast cancer: Implications for proliferation and migration in vitro and metastasis in vivo
.
Clinical Cancer Research
. 14:4961.
2008
2008
Telomere maintenance in laser capture microdissection - Purified Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivo
.
Clinical Cancer Research
. 14:4971.
2008
2008
Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis model
2008
2008
Therapeutic potential of genetically modified mesenchymal stem cells
2008
2008
Clinical significance of a novel single nucleotide polymorphism in the 5′ untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma
.
Frontiers in Bioscience-Landmark
. 13:1050-1061.
2008
2008
Systemic osteoprotegerin gene therapy restores tumor-induced bone loss in a therapeutic model of beast cancer bone metastasis
.
Molecular Therapy
. 16:871-878.
2008
2007
Bone homing of mesenchymal stem cells by ectopic α4 integrin expression
2007
2007
Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP ,model
.
Cancer Research
. 67:5789-5797.
2007
2007
Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus
2007
2007
Notch1 augments intracellular trafficking of adeno-associated virus type 2
.
Journal of Virology
. 81:2069-2073.
2007
2007
Intraperitoneal gene therapy by rAAV provides long-term survival against epithelial ovarian cancer independently of survivin pathway
2007
2006
Airway epithelium directed gene therapy for cystic fibrosis
.
Medicinal Chemistry
. 2:499-503.
2006
2006
Anti-Aβ single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease
.
Neurobiology of Disease
. 23:502-511.
2006
2006
Activators of viral gene expression in polarized epithelial monolayers identified by rapid-throughput drug screening
2006
2006
Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands
2006
2005
Determination of osteoprogenitor-specific promoter activity in mouse mesenchymal stem cells by recombinant adeno-associated virus transduction
2005
2005
Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma
.
Cancer Research
. 65:10041-10049.
2005
2005
Genomic stability of self-complementary adeno-associated virus 2 during early stages of transduction in mouse muscle in vivo
.
Human gene therapy. Clinical development
. 16:1047-1057.
2005
2005
Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer
.
Clinical Cancer Research
. 11:1342-1347.
2005
2005
Antiangiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of the soluble FMS-like tyrosine kinase-1 receptor
.
Cancer Gene Therapy
. 12:26-34.
2005
2004
Augmentation of antitumor activity of a recombinant adeno-associated virus carcinoembryonic antigen vaccine with plasmid adjuvant
.
Human gene therapy. Clinical development
. 15:856-864.
2004
2004
Detection of disseminated breast cancer growth and treatment response using non-invasive bioluminescence imaging.
.
Journal of Clinical Oncology
. 22:742.
2004
2004
Adeno-Associated Virus 2-Mediated Antiangiogenic Cancer Gene Therapy: Long-Term Efficacy of a Vector Encoding Angiostatin and Endostatin over Vectors Encoding a Single Factor
.
Cancer Research
. 64:1781-1787.
2004
2004
Anti-angiogenic gene therapy for cancer (review).
.
International Journal of Oncology
. 25:335-343.
2004
2004
Delivery of DNA to tumor cells in vivo using adeno-associated virus.
.
Methods in Molecular Biology
. 246:237-243.
2004
2004
Gene therapy for osteoinduction
2004
2004
Osteogenic differentiation of recombinant adeno-associated virus 2-transduced murine mesenchymal stem cells and development of an immunocompetent mouse model for ex vivo osteoporosis gene therapy
.
Human gene therapy. Clinical development
. 15:1197-1206.
2004
2004
Parvovirus vectors for cancer gene therapy
.
Expert Opinion on Biological Therapy
. 4:53-64.
2004
2002
Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands
.
Journal of Virology
. 76:12900-12907.
2002
2002
Adenoassociated virus vectors for genetic immunization
.
Immunologic Research
. 26:247-253.
2002
2001
Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: Implications for ex vivo immunotherapy
.
Journal of Virology
. 75:9493-9501.
2001
2001
Adeno-associated virus for cancer gene therapy
.
Cancer Research
. 61:6313-6321.
2001
1999
Adeno-associated virus 2-mediated transduction and erythroid lineage- restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells
.
Stem Cells and Development
. 8:585-592.
1999
1998
Adeno-associated virus type 2-mediated gene transfer: Correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein transgene expression in human cells in vitro and murine tissues in vivo
.
Journal of Virology
. 72:1593-1599.
1998
1998
Adeno-associated virus type 2-mediated gene transfer: Role of epidermal growth factor receptor protein tyrosine kinase in transgene expression
.
Journal of Virology
. 72:9835-9843.
1998
1998
Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination
.
Journal of Virology
. 72:5472-5480.
1998
1998
Recombinant human parvovirus B19 vectors: Erythroid cell-specific delivery and expression of transduced genes
.
Journal of Virology
. 72:5224-5230.
1998
1997
Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina
.
Current Eye Research
. 16:949-956.
1997
1997
Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression
1997
1997
Adeno-associated virus 2-mediated gene transfer in vivo: Organ-tropism and expression of transduced sequences in mice
.
Gene
. 190:203-210.
1997
1997
Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells
.
Human gene therapy. Clinical development
. 8:275-284.
1997
1997
Adeno-associated virus type 2 DNA replication in vivo: Mutation analyses of the D sequence in viral inverted terminal repeats
.
Journal of Virology
. 71:3077-3082.
1997
1997
Adeno-associated virus type 2-mediated transduction in primary human bone marrow-derived CD34
+
hematopoietic progenitor cells: Donor variation and correlation of transgene expression with cellular differentiation
.
Journal of Virology
. 71:8262-8267.
1997
1997
Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo
.
Journal of Virology
. 71:3098-3104.
1997
1997
Encapsidation of adeno-associated virus type 2 rep proteins in wild- type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells
.
Journal of Virology
. 71:7361-7371.
1997
1996
Adeno-associated virus 2-mediated transduction and erythroid lineage-specific expression in human hematopoietic progenitor cells
.
Current Topics in Microbiology and Immunology
. 218:93-117.
1996
1996
Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: Human megakaryocytic leukaemia cells are non-permissive for AAV infection
.
Journal of General Virology
. 77:1111-1122.
1996
1996
Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: Selective encapsidation of viral genomes in progeny virions
.
Journal of Virology
. 70:1668-1677.
1996
1995
Rescue and replication signals of the adeno-associated virus 2 genome
.
Journal of Molecular Biology
. 250:573-580.
1995
1995
Mouse silver. Mutation is caused by a single base insertion in the putative cytoplasmic domain of Pmel 17
.
Nucleic Acids Research
. 23:154-158.
1995
1995
Cord Blood Transplantation and the Potential for Gene Therapy: Gene Transduction Using a Recombinant Adeno‐Associated Viral Vector
.
Annals of the New York Academy of Sciences
. 770:105-115.
1995
1995
Transcriptional transactivation of parvovirus B19 promoters in nonpermissive human cells by adenovirus type 2
.
Journal of Virology
. 69:8096-8101.
1995
1994
Suppression of human α-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectors
.
Journal of Experimental Medicine
. 179:733-738.
1994
1994
Structural organization of the human tyrosinase gene and sequence analysis and characterization of its promoter region
.
Journal of Investigative Dermatology
. 102:744-748.
1994
1992
A cis‐Acting Element Involved in Mouse Tyrosinase Gene Expression and Partial Purification of its Binding Protein
.
Pigment Cell and Melanoma Research
. 5:155-161.
1992
1992
Amelioration of clinical severity through raised fetal hemoglobin in sickle cell anaemia
.
Indian Journal of Pediatrics
. 59:85-90.
1992
1992
Enzymes of the Pentose Phosphate Pathway in Glutathione-Regulated Membrane Protection in β-Thalassaemia
.
Clinical Chemistry and Laboratory Medicine
. 30:481-484.
1992
1992
Enzymes of the pentose phosphate pathway in glutathione-regulated membrane protection in β-thalassaemia
.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies
. 30:481-484.
1992
1990
Elevated G gamma:A gamma globin chain ratio in homozygous beta thalassemia.
.
Clinical Biochemistry
. 23:529-531.
1990
1990
Elevated
G
γ:
A
γ globin chain ratio in homozygous beta thalassemia
.
Clinical Biochemistry
. 23:529-531.
1990
1989
Influence of gamma chains in in vitro globin synthesis in β° and β
+
homozygous thalassaemia
.
Medical science research
. 17:409-410.
1989
Research
Principal Investigator On
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership - Pilot Project #2
awarded by
National Cancer Institute/NIH/DHHS
AAV-Based Plasmacytoid Dentritic Cell Cancer Vaccine
awarded by
CLEVELAND CLINIC FOUNDATION
AAV-Mediated Gene Therapy for Metabolic Bone Disease
awarded by
National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS
Co-targeting Immunosuppression and Skeletal Pathology for Metastatic Breast Cancer Therapy
awarded by
METAVIVOR
Gene-Engineered and Targeted Stem Cell Therapy for Myeloma
awarded by
National Cancer Institute/NIH/DHHS
Osteoimmune Mechanisms of Segmental Bone Fracture Healing and Therapy
awarded by
DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY
Regenerative Stem Cell Therapy for Breast Cancer Bone Metastasis
awarded by
DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY
Targeted Stem Cell Therapy Coupling Angiogenesis and Osteogenesis for Bone Defect
awarded by
National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS
Targeted Therapy for Breast Cancer with Osteolytic Bone Damage
awarded by
National Cancer Institute/NIH/DHHS
Targeting the Androgen Receptor Axis Affects Macrophage Polarization in Castration Resistant Prostate Cancer
awarded by
MIKE SLIVE FOUNDATION
UAB Core Center for Basic Skeletal Research
awarded by
National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS
UAB Core Center for Basic Skeletal Research - Core A
awarded by
National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS
rAAV Vaccine Vector
awarded by
National Cancer Institute/NIH/DHHS
Investigator On
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
awarded by
National Cancer Institute/NIH/DHHS
3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership
awarded by
National Cancer Institute/NIH/DHHS
A Specific Screening Strategy to Reduce Prostate Cancer Mortality
awarded by
DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY
COMPLETED - Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Project 1: CD24-Dependent Inactivation of Mutant p53 in Metastatic Castration-Resistant Prostate Cancer
awarded by
National Cancer Institute/NIH/DHHS
Characterizing the Negative Signaling in Dendritic Cells and Macrophages to Attenuate Inflammation and Bone Destruction in Rheumatoid Arthritis
awarded by
National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS
Ga13 Signaling Attenuates Periodontal Inflammation and Alveolar Bone Loss in the Mouse Model of Age-Associated Periodontitis
awarded by
National Institute of Dental and Craniofacial Research/NIH/DHHS
Heparanase Regulation of Myeloma Metastasis: Mechanism and Therapy
awarded by
National Cancer Institute/NIH/DHHS
Inhibiting Inflammation and Bone Erosion in Periodontal Disease by Targeting Cell Endogenous Negative Signaling
awarded by
National Institute of Dental and Craniofacial Research/NIH/DHHS
Investigating the Expression, Role and Targeting of Collagen Modifying Prolyl 4-hydroxylase P4HA1 in Prostate Cancer Progression and Metastasis
awarded by
DOD - Department of Defense
Lumina III System for UAB Optical Imaging
awarded by
NIH - OFFICE OF THE DIRECTOR
Modeling Dynamic Immune Cell Modulation in a 3-D Tissue Engineered Platform to Enhance Patient-specific Immunotherapy for Lung Cancer
awarded by
National Cancer Institute/NIH/DHHS
Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership
awarded by
National Cancer Institute/NIH/DHHS
Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: (Admin Supplement) to Support Development of PDX at UAB CCC
awarded by
National Cancer Institute/NIH/DHHS
Multifunctional Nanomatrix for Percutaneous Osteointegrated Prostheses
awarded by
ALABAMA DEPARTMENT OF ECONOMIC AND COMMUNITY AFFAIRS
Teaching
Teaching Activities
GBS776 - JC- Cancer Biology (Fall Term 2021)
GBS776 - JC- Cancer Biology (Fall Term 2022)
GBS776 - JC- Cancer Biology (Spring Term 2022)
GBSC742 - Student Theme Meeting Course (Fall Term 2020)
GBSC742 - Student Theme Meeting Course (Fall Term 2021)
GBSC742 - Student Theme Meeting Course (Fall Term 2022)
GBSC742 - Student Theme Meeting Course (Spring Term 2021)
GBSC742 - Student Theme Meeting Course (Spring Term 2022)
PAT791 - Adv Molecular/Cell Pathology (Fall Term 2007)
PAT791 - Adv Molecular/Cell Pathology (Fall Term 2008)
PAT791 - Adv Molecular/Cell Pathology (Fall Term 2009)
PAT791 - Adv Molecular/Cell Pathology (Fall Term 2010)
PAT791 - Adv Molecular/Cell Pathology (Fall Term 2011)
PAT791 - Adv Molecular/Cell Pathology (Fall Term 2012)
PAT791 - Adv Molecular/Cell Pathology (Fall Term 2013)
PAT791 - Adv Molecular/Cell Pathology (Fall Term 2014)
PAT791 - Adv Molecular/Cell Pathology (Fall Term 2015)
PAT791 - Adv Molecular/Cell Pathology (Spring Term 2008)
PAT791 - Adv Molecular/Cell Pathology (Spring Term 2009)
PAT791 - Adv Molecular/Cell Pathology (Spring Term 2010)
PAT791 - Adv Molecular/Cell Pathology (Spring Term 2011)
PAT791 - Adv Molecular/Cell Pathology (Spring Term 2012)
PAT791 - Adv Molecular/Cell Pathology (Spring Term 2013)
PAT791 - Adv Molecular/Cell Pathology (Spring Term 2014)
PAT791 - Adv Molecular/Cell Pathology (Spring Term 2015)
Background
Education And Training
Doctor of Philosophy in Genetics,
University of Madras
1989
Master's Level Degree in Genetics,
University of Madras
1984
Contact
Full Name
Selvarangan
Ponnazhagan